May 11-14, 2026
Hynes Convention CenterBoston, MADr. Doug Dellinger, PhDCEO and Co-Founder at CirenaSpeaker
Profile
Doug Dellinger earned his Ph.D. with Marvin Caruthers; his research is responsible modern phosphoramidite monomer production. He invented several internucleotide bond modifications, for in vivo stability. He advanced DNA and RNA synthesis at Ionis Pharmaceuticals, MetaSense Technologies, and led research in Hewlett-Packard/Agilent Laboratories for 3 decades, notably developing ink-jet synthesized DNA arrays. In 2011, he co-authored a breakthrough RNA synthesis, and pioneered chemical synthesis of modified sgRNAs, and pegRNAs. In 2024, Doug co-founded Cirena, Inc.
Agenda Sessions
Short Oral Poster Presentation: High-Yielding, High Purity Chemical Synthesis of Ultra Long RNA to 400 Nucleotides
, 3:15pmView Session